Why the Ramsay Health Care (ASX:RHC) share price tumbled lower today

The Ramsay Health Care Limited (ASX:RHC) share price tumbled lower on Thursday after announcing a major acquisition in the UK…
The post Why the Ramsay Health Care (ASX:RHC) share price tumbled lower today appeared first on The Motley Fool Australia. –

The Ramsay Health Care Limited (ASX: RHC) share price was out of form on Thursday.

The private hospital operator’s shares fell 3.5% to $62.30.

Why did the Ramsay share price tumble?

The Ramsay share price came under pressure on Thursday after the market responded cautiously to the announcement of a new acquisition.

After the market close on Wednesday, Ramsay announced that it had made an offer of 1 billion pounds (A$1,822 million) to acquire 100% of Spire Healthcare. It is a London Stock Exchange-listed independent hospital group in the United Kingdom with a focus on the private patient market. It is also a leading provider of high-acuity care.

The Spire Board is unanimously recommending its shareholders vote in favour of the scheme. It also notes that major shareholders and directors, accounting for 30.4% of its shares, have made irrevocable undertakings to vote in its favour.

Management believes the acquisition will be transformational for Ramsay’s UK business. It also expects to deliver benefits of at least 26 million pounds per annum from procurement savings, improved capacity utilisation, and cessation of UK listing costs. This is forecast to result in high single digit earnings per share accretion in FY 2024.

What was the response?

One leading broker that gave the acquisition a lukewarm response was Citi. In response to the news, the broker has held firm with its neutral rating and $67.00 price target.

Citi notes that the deal will increase its market share in the UK to 25% and is expected to generate decent synergies. However, the broker has some doubts over whether those synergies will be realised.

Commenting on the acquisition, Citi said: “Guiding to high single digit EPS accretion in FY24 Ramsay Healthcare has announced that it has bid 240p per share for Spire Healthcare Group, a 24% premium to the last close in an agreed deal. This values the equity of Spire at ~£1bn (A$1.822bn) and the EV post AASB16 at £2.064bn.”

“The combined group would have ~25% of the UK private hospital market, with Spire currently having ~17% market share (~£1bn revenue in CY19) and RHC ~8% market share (~£540m revenue in FY19).”

“In CY19, Spire reported EBIT of £98m and RHC said its CY19 (pre-exceptional items) EBIT was £42m (but reported £26m in FY19). The company is forecasting “at least” £26m in synergies for the combined group, which seems reasonable on a combined revenue of ~£1.5b, although when Ramsay acquired Capio it made similar statements, and it is not obvious that those synergies have been realised (although in a different market).”

Learn where to invest $1,000 right now

When investing expert Scott Phillips has a stock tip, it can pay to listen. After all, the flagship Motley Fool Share Advisor newsletter he has run for more than eight years has provided thousands of paying members with stock picks that have doubled, tripled or even more.*

Scott just revealed what he believes could be the five best ASX stocks for investors to buy right now. These stocks are trading at near dirt-cheap prices and Scott thinks they could be great buys right now.

*Returns as of May 24th 2021

More reading

Why ALS, Costa, Fisher & Paykel Healthcare, & Ramsay shares are falling

ASX 200 flat: Costa crashes & Fisher & Paykel Healthcare tumbles

5 things to watch on the ASX 200 on Thursday

Ramsay Health Care (ASX:RHC) share price on watch after announcing major UK acquisition
ASX 200 drops, ALS jumps, Fletcher Building rises

The post Why the Ramsay Health Care (ASX:RHC) share price tumbled lower today appeared first on The Motley Fool Australia.

Trade The World Anywhere & Anytime!

Mobile app platform with over 50,000 global listed securities across 12 markets (over 70% global market capitalisation), right from your Android or iOS device.

Integrated with exclusive trading idea and investment analysis tools to help you find actionable insight on virtually every financial instrument across our 12 global markets, to help you optimise your trading strategies.

Refer Your Friends

Tell your friends about Monex and gift them FREE access to our trading tools.

We respect your privacy and will only send this one email notification to your friends. 

Share With Your Friends

Share on facebook
Share on twitter
Share on linkedin

Monex Trading Tools Access and Usage Terms

The Monex Trading Tools (referred to as ‘tools’ hereafter) are available to you inside your client portal;

To activate access to the tools, you must have a verified and approved trading account and have made a deposit of at least AUD $1000.

An active and funded account with a positive trading balance is required to continue to have access to the tools;

Although the tools are available to you indefinitely, Monex Securities may at it’s discretion disable access to the tools in the future;

Monex securities reserves the right to change these terms and conditions from time to time, as it sees fit, without notice.

Important Notice
iOS & Android App - 12 International Markets & Over 70% Global Market Cap. $0 Brokerage On US Trades. Click Here!